Ep. 28 Aneil Mallavarapu on Building and Monetizing TechBio Platforms, Storytelling and Why Diagnostics Won't Save a System Designed to Fail

In this expansive episode, Aneil Mallavarapu delivers a masterclass on what TechBio is really about and why most investors and founders are still getting it wrong. We dig into the communication gap between technical genius and venture capital, the brutal economics of research tools, the data dilemmas in wet AI, and why the future belongs to founders who can both build deep and speak simply.
Aneil shares hard truths about platform strategy, revenue (yes, revenue), and the myth of “cool diagnostics” inside a broken healthcare system. But this isn’t just about critique. It’s a hopeful, strategic call for a new generation of purposeful companies, built not only for returns but for impact. If you're working at the intersection of biology, tech, and meaning, this is the one to listen to.